PURE Bioscience, Inc. (PURE) Operating cash flow 2016–2025
PURE Bioscience, Inc. (PURE) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$2.0MFY2025 · since FY2016: -$5.0M → -$2.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$2.0M | +20.4% |
| FY2024 | -$2.5M | +22.8% |
| FY2023 | -$3.3M | -35.6% |
| FY2022 | -$2.4M | -107.2% |
| FY2021 | -$1.2M | -274.4% |
| FY2020 | $669,000 | +122.4% |
| FY2019 | -$3.0M | +23.1% |
| FY2018 | -$3.9M | +14.8% |
| FY2017 | -$4.6M | +8.6% |
| FY2016 | -$5.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice